Reby Advisors’s Medtronic MDT Stock Holding History

Reby Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$73K	Buy	+621	New	+$68.4K	0.02%	182

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Reby Advisors's MDT Position: Q4 2020 in Review

Reby Advisors opened a new position in Medtronic (MDT) in Q4 2020: 621 shares worth $73K. The stake represents 0.02% of the portfolio and ranks #182 among its holdings.

1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

Reby Advisors held 621 shares of Medtronic worth $73K as of Q4 2020.
Medtronic was a new Reby Advisors position in Q4 2020.
Medtronic made up 0.02% of Reby Advisors's portfolio in Q4 2020, its #182 holding.
1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Reby Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.